SAN FRANCISCO, April 8, 2026 /PRNewswire/ -- KushoAI, an AI-native platform for API testing and software reliability, has introduced APIEval-20, an open benchmark designed to evaluate how effectively ...

Don't miss the big stories. Like us on Facebook. The API testing market is being reshaped by AI — but most tools charge extra for it, lock it behind enterprise tiers, or barely offer it at all. Apidog ...

Learn how Postman API Testing simplifies automation with Collections, Environments, and Postman Newman. Discover an efficient REST client and API testing tool for seamless workflows. Postman API - ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Dany Lepage discusses the architectural ...

Sauce Labs Inc., a continuous testing solutions provider, today announced the general availability of its Real Device Access API, changing how the company delivers mobile testing infrastructure and ...

The Python extension now supports multi-project workspaces, where each Python project within a workspace gets its own test tree and Python environment. This document explains how multi-project testing ...

kicad-python is the official Python bindings for the KiCad IPC API. This library makes it possible to develop scripts and tools that interact with a running KiCad session. The KiCad IPC API can be ...

Cybersecurity researchers are calling attention to a new campaign that's leveraging GitHub-hosted Python repositories to distribute a previously undocumented JavaScript-based Remote Access Trojan (RAT ...

The North Pole Express holiday train trips will use diesel locomotives instead of the historic Pere Marquette 1225 steam engine. An unforeseen mechanical issue with the steam locomotive was discovered ...

Cdymax Pharma has been slapped with a warning letter from the FDA outlining two observations against the Bangalore, India-based API maker, both linked to testing shortfalls. The letter comes in ...

Across primary sites, histological subtypes, and mitotic count categories, clinicopathological factors and gene-expression profile results were consistent for discriminating SLN positivity rates.